Omega-3 fatty acids, specialized pro-resolving mediators, and depression: A mechanistic meta-analysis of precursors and clinical implications
Abstract
BACKGROUND
Omega-3 polyunsaturated fatty acids (n-3 PUFAs), especially eicosapentaenoic acid (EPA), exhibit adjunctive antidepressant efficacy despite negligible detectable levels in the brain. Emerging evidence implicates specialized pro‑resolving mediators (SPMs); bioactive n-3 PUFA metabolites offer a coherent pathway by actively resolving inflammation, enhancing tissue repair, and supporting neuronal function. To test whether n‑3 PUFA supplementation activates pro‑resolving biology in humans, this meta‑analysis quantified effects on circulating SPM precursors.
METHODS
We systematically searched PubMed, EMBASE, Web of Science, GOED, and the Cochrane Library (up to May 18, 2026) to identify RCTs examining the impact of n-3 PUFAs supplementation on circulating SPM precursors 18-hydroxyeicosapentaenoic acid (18-HEPE) and 17-hydroxydocosahexaenoic acid (17-HDHA). Meta-analysis was performed using Review Manager 5.4.1 with random-effects models.
RESULTS
Eleven RCTs, comprising 810 participants, were included. N-3 PUFAs supplementation significantly and robustly increased the concentrations of both circulating SPM precursors: 18-HEPE (SMD = 1.05, 95% CI 0.54-1.55, Z = 4.08, P = 0.0001) and 17-HDHA (SMD = 0.69, 95% CI 0.19-1.18, Z = 2.72, P = 0.006). Importantly, subgroup analyses revealed that this increase was selectively amplified in patient populations characterized by a significant inflammatory, metabolic, and oxidative burden, including peripheral artery disease (PAD),…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 810 participants or records.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.